Development of the Oncology Opportunity Cost Assessment Tool

Study Overview
=================
Brief Summary
-----------------
This study develops and tests an instrument to measure opportunity costs called the Oncology Opportunity Cost Assessment Tool (OOCAT) in cancer patients. Patients experience significant costs, both direct financial as well as indirect costs, associated with seeking cancer treatment. While the direct financial impact of care on patients is receiving increased attention, other important consequences, such as opportunity cost, remain largely unmeasured. Opportunity cost is an economics term that refers to the loss of potential benefits from other options when one option is chosen - if resources are used for one purpose, they are no longer available for the next best option. The information and knowledge gained from this study may help researchers develop the OOCAT, which may allow them to understand the opportunity cost of treatment for each patient. The OOCAT may then be used to determine not just the best medications for patients, but also the best comprehensive treatment plan that will allow them to get the right treatment in the right place at the right time.

Official Title
-----------------
Development of the Oncology Opportunity Cost Assessment Tool (OOCAT)

Conditions
-----------------
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm

Intervention / Treatment
-----------------
* Behavioral: Focus Group
* Other: Interview
* Other: Research or Clinical Assessment Tool


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Treated for cancer at one of the 3 participating sites (Jefferson Center City, Jefferson Methodist Hospital, Jefferson Abington) English speaking Able to attend and participate in a focus group Exclusion Criteria: Treated at a Jefferson site other than the ones mentioned Non-English Speaking

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
Male

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Health Services Research (focus group, interview, OOCAT)<br>FOCUS GROUP: Patients participate in focus group session over 60-90 minutes. COGNITIVE INTERVIEW: Patients complete cognitive interview on the clarity, interpretability, and ease of use of the OOCAT. FEASIBILITY TESTING: Patients receive OOCAT at the point of care, online, or via telephone, per patients' preference. | Behavioral: Focus Group<br>* Participate in focus group<br>Other: Interview<br>* Complete cognitive interview<br>Other: Research or Clinical Assessment Tool<br>* Receive OOCAT<br>* Other names: Clinical Assessment Tool, Clinical Assessment Tool, Clinical or Research Assessment Tool;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient-level opportunity costs associated with oncology care | Patient-identified themes that contribute to opportunity cost will be generated via patient focus groups | 1 Day of Interview | 
| Development of the Oncology Opportunity Cost Assessment Tool (OOCAT) | Will organize themes into domains and will generate items representing each of the themes for inclusion in an instrument designed to measure patient opportunity cost of seeking care. Will perform cognitive interviews with a random sampling of patients from the cancer center to test initial instrument items to ensure content validity and clarity of each item. | 1 Day of Interview | 
| Implementation of OOCAT | Will test the instrument as developed with patients receiving oncology care across the Jefferson Health System to gather preliminary data informing the reliability of the scale to measure opportunity cost of seeking care. | 1 Day of OOCAT administration |